StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Non-GAAP adjusted earnings before provision for taxes by Quarter

Non-GAAP adjusted earnings before provision for taxes on income ($M) ($M)

QuarterlyAnnual

Johnson & Johnson Non-GAAP adjusted earnings before provision for taxes: $7,672M in Q3 2026, down 9.1% from a year earlier.

Latest, Q3 2026
7,672
Period ended Sep 30, 2026
Change on a year earlier
-9.1%
8,436 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
36
Documents cited below

Where the Q3 2026 figure comes from

“|| Earnings before provision for taxes on income | $ | 7,672 | 30.2 | $ | 8,436 | 35.2 | (9.1)”

Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗

Reported in Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP adjusted earnings before provision for taxes on income ($M) ($M)Year on yearSource
Q3 2026Sep 30, 20267,672-9.1%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 20268,660+5.8%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 20267,821-2.4%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 20257,046+30.0%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 20258,436+15.9%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2025Jun 29, 20258,188-2.6%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2025Mar 30, 20258,011+1.7%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2024Dec 29, 20245,421-13.1%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2024Sep 29, 20247,277-9.4%Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2024Jun 30, 20248,404+5.0%Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2024Mar 31, 20247,877+4.5%Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2023Dec 31, 20236,237-3.8%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2023Oct 1, 20238,033+13.8%Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2023Jul 2, 20238,005-2.0%Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2023Apr 2, 20237,536-8.3%Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2022Jan 1, 20236,482+2.3%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗

Breakdown

What makes up non-GAAP adjusted earnings before provision for taxes

Cite this data

StockData. (2026). Johnson & Johnson Non-GAAP adjusted earnings before provision for taxes ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj-pti

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.